Correlation Between Viatris and Provectus Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Provectus Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Provectus Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Provectus Biopharmaceuticals, you can compare the effects of market volatilities on Viatris and Provectus Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Provectus Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Provectus Biopharmaceutica.

Diversification Opportunities for Viatris and Provectus Biopharmaceutica

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viatris and Provectus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Provectus Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Provectus Biopharmaceutica and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Provectus Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Provectus Biopharmaceutica has no effect on the direction of Viatris i.e., Viatris and Provectus Biopharmaceutica go up and down completely randomly.

Pair Corralation between Viatris and Provectus Biopharmaceutica

If you would invest  11.00  in Provectus Biopharmaceuticals on January 21, 2024 and sell it today you would earn a total of  0.00  from holding Provectus Biopharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Provectus Biopharmaceuticals

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viatris has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Viatris is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Provectus Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Provectus Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Provectus Biopharmaceutica is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Viatris and Provectus Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Provectus Biopharmaceutica

The main advantage of trading using opposite Viatris and Provectus Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Provectus Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Provectus Biopharmaceutica will offset losses from the drop in Provectus Biopharmaceutica's long position.
The idea behind Viatris and Provectus Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies